POS-045 EARLY RENAL REPLACEMENT THERAPY MAY REDUCE THE ALL-CAUSE MORTALITY OF SEVERE COVID-19

• J. Qian,
• M. Wang,
• H. You,
• J. Luo,
• S. Li,
• S. Chen,
• Y. Chen,
• X. Li,
• K. Wang,
• W.Z. Zhang,
• L. Yuan,
• L. Ni,
• J. Chen

Affiliations

J. Qian

Huashan Hospital Fudan University, Department of Nephrology, Shanghai, China

M. Wang

Huashan Hospital Fudan University, Department of Nephrology, Shanghai, China

H. You

Huashan Hospital Fudan University, Department of Nephrology, Shanghai, China

J. Luo

Fudan University, Department of Biostatistics, School of Public Health, Shanghai, China

S. Li

Huashan Hospital Fudan University, Department of Pulmonary and Critical Care Medicine, Shanghai, China

S. Chen

Huashan Hospital Fudan University, Department of Infectious Diseases, Shanghai, China

Y. Chen

Huashan Hospital Fudan University, Institute of Antibiotics, Shanghai, China

X. Li

Huashan Hospital Fudan University, Department of Critical Care Medicine, Shanghai, China

K. Wang

Huashan Hospital Fudan University, Department of Nephrology, Shanghai, China

W.Z. Zhang

Huashan Hospital Fudan University, Department of Nephrology, Shanghai, China

L. Yuan

Huashan Hospital Fudan University, Department of Nursing, Shanghai, China

L. Ni

Huashan Hospital Fudan University, Department of Nephrology, Shanghai, China

J. Chen

Huashan Hospital Fudan University, Department of Nephrology, Shanghai, China